跳至主要内容
临床试验/CTRI/2025/08/093476
CTRI/2025/08/093476尚未招募不适用

To study the clinical characteristics and duration of ventilator support in patients who received sugammadex during their ICU stay

Dr Amarja Ashok Havaldar1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2025年9月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
15
试验地点
1
主要终点
To assess the impact of sugammadex on the duration of mechanical ventilation

研究概览

简要总结

Sugamadex is a reversal agent used predominantly in perioperative settings. There are not enough studies looking at the use of this drug in the ICU. This study is a retrospective study evaluating the use of this drug in the ICU population. The primary outcome is the duration of ventilator days after the administration of the sugammadex.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients on invasive mechanical ventilation Patients received sugammadex.

排除标准

  • Patients who have not received sugammadex will be excluded.

结局指标

主要结局

To assess the impact of sugammadex on the duration of mechanical ventilation

时间窗: 4 weeks

次要结局

  • The length of ICU stay in patients who received sugammadex.(1 week)

研究者

发起方
Dr Amarja Ashok Havaldar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Amarja Havaldar

St Johns medical college

研究点 (1)

Loading locations...

相似试验